Detalles de la búsqueda
1.
Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF.
Circulation
; 147(22): 1670-1683, 2023 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37039015
2.
Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial.
Circulation
; 148(22): 1735-1745, 2023 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37632455
3.
Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial.
Circulation
; 148(24): 1945-1957, 2023 12 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37830208
4.
Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial.
Circulation
; 147(14): 1067-1078, 2023 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36876483
5.
Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER.
Circulation
; 147(8): 624-634, 2023 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36342789
6.
Heart Failure, Investigator-Reported Sleep Apnea and Dapagliflozin: A Patient-Level Pooled Meta-Analysis of DAPA-HF and DELIVER.
J Card Fail
; 30(3): 436-448, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38104937
7.
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER.
Eur Heart J
; 44(24): 2170-2183, 2023 06 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37220172
8.
Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF.
Circulation
; 146(13): 980-994, 2022 09 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35971840
9.
Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HF.
Circulation
; 146(6): 438-449, 2022 08 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35442064
10.
Operational challenges and mitigation measures during the COVID-19 pandemic-Lessons from DELIVER.
Am Heart J
; 263: 133-140, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37220822
11.
Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction : A Post Hoc Analysis of the DAPA-HF Trial.
Ann Intern Med
; 175(6): 820-830, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35467935
12.
Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation.
Eur Heart J
; 43(42): 4469-4479, 2022 11 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36017729
13.
Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF.
Circulation
; 143(20): 1962-1972, 2021 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33832352
14.
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF.
Circulation
; 143(4): 298-309, 2021 01 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33040613
15.
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
N Engl J Med
; 381(21): 1995-2008, 2019 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31535829
16.
Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF.
Eur Heart J
; 42(36): 3727-3738, 2021 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34448003
17.
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study.
Eur Heart J
; 42(31): 3011-3020, 2021 08 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34080008
18.
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF.
Circulation
; 141(2): 100-111, 2020 01 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31736328
19.
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial.
Circulation
; 141(2): 90-99, 2020 01 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31736335
20.
Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF.
Circulation
; 142(11): 1040-1054, 2020 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32673497